Case Study: Clinical-Stage in Vivo Cell Therapy Company unifies bioprocess data and scales from 2L to 200L with Invert

A Invert Case Study

Preview of the Clinical-Stage in Vivo Cell Therapy Company Case Study

Clinical-Stage in Vivo Cell Therapy Company avoids $400K in integration costs with Invert

A clinical-stage in vivo cell therapy company faced significant challenges in scaling its bioprocess operations across two sites and five different bioreactor systems. Their data was fragmented across multiple vendors and scales, requiring extensive manual effort to reconcile process data with experimental context. Building a custom in-house solution was estimated to cost up to $400K and take 12-18 months. The company turned to Invert to replace its legacy data historian with a platform built for batch-based bioprocess operations.

Invert connected directly to all five bioreactor systems via OPC-UA/DA and integrated with the company's existing ELN, creating a unified, batch-aware environment for monitoring and analysis. This solution avoided up to $400,000 in integration costs and 12-18 months of build effort. It eliminated the need for dedicated data engineering headcount and reduced batch analysis preparation from days to near real-time, enabling seamless scale-up across production sites with no workflow disruption.


View this case study…

Invert

3 Case Studies